Medicine recalls
|
| |
| Taiwan: Recall of "科基"血凝素第八因子注射劑(重組體)1000IU/瓶 [KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 1000 IU/VIAL], "科基"血凝素第八因子注射劑(重組體)500IU/瓶 [KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 500 IU/VIAL] and "科基"血凝素第八因子注射劑(重組體)250IU/瓶 [KOGENATE FS, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FORMULATED WITH SUCROSE, 250 IU/VIAL] |
| |
In Hong Kong, Kogenate FS for Inj 1000IU (HK-54067), Kogenate FS for Inj 250IU (HK-54068) and Kogenate FS for Inj 500IU (HK-54069) are pharmaceutical products registered by Bayer Healthcare Ltd (Bayer), and are prescription only medicines. So far, the Department of Health has not received any adverse drug reaction case related to the products. Related news was previously issued by the Health Canada and MHRA, and was posted on the Drug Office website on 28 July and 12 August 2016 respectively. As confirmed with Bayer, the above products have never been marketed in Hong Kong.
Please refer to the following Chinese website for details:
http://www.drugoffice.gov.hk/eps/news/../26706.html
Ends/ Friday, August 19, 2016
Issued at HKT 15:00
|
| |
|
